The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Oral Peptide Drug Market Research Report 2022

Global Oral Peptide Drug Market Research Report 2022

Publishing Date : Apr, 2022

License Type :
 

Report Code : 1689057

No of Pages : 80

Ask Your Query
Synopsis
Market Analysis and Insights: Global Oral Peptide Drug Market
The drugs give through oral.
The global Oral Peptide Drug market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Linaclotide accounting for % of the Oral Peptide Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Oral Peptide Drug market size is valued at US$ million in 2021, while the North America and Europe Oral Peptide Drug are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Oral Peptide Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oral Peptide Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oral Peptide Drug market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oral Peptide Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oral Peptide Drug market.
Global Oral Peptide Drug Scope and Market Size
Oral Peptide Drug market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Oral Peptide Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide
Segment by Application
Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Peptide Drug Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Market by Application
1.3.1 Global Oral Peptide Drug Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oral Peptide Drug Market Perspective (2017-2028)
2.2 Oral Peptide Drug Growth Trends by Region
2.2.1 Oral Peptide Drug Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Oral Peptide Drug Historic Market Size by Region (2017-2022)
2.2.3 Oral Peptide Drug Forecasted Market Size by Region (2023-2028)
2.3 Oral Peptide Drug Market Dynamics
2.3.1 Oral Peptide Drug Industry Trends
2.3.2 Oral Peptide Drug Market Drivers
2.3.3 Oral Peptide Drug Market Challenges
2.3.4 Oral Peptide Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Peptide Drug Players by Revenue
3.1.1 Global Top Oral Peptide Drug Players by Revenue (2017-2022)
3.1.2 Global Oral Peptide Drug Revenue Market Share by Players (2017-2022)
3.2 Global Oral Peptide Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Peptide Drug Revenue
3.4 Global Oral Peptide Drug Market Concentration Ratio
3.4.1 Global Oral Peptide Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Peptide Drug Revenue in 2021
3.5 Oral Peptide Drug Key Players Head office and Area Served
3.6 Key Players Oral Peptide Drug Product Solution and Service
3.7 Date of Enter into Oral Peptide Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Peptide Drug Breakdown Data by Type
4.1 Global Oral Peptide Drug Historic Market Size by Type (2017-2022)
4.2 Global Oral Peptide Drug Forecasted Market Size by Type (2023-2028)
5 Oral Peptide Drug Breakdown Data by Application
5.1 Global Oral Peptide Drug Historic Market Size by Application (2017-2022)
5.2 Global Oral Peptide Drug Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Oral Peptide Drug Market Size (2017-2028)
6.2 North America Oral Peptide Drug Market Size by Country (2017-2022)
6.3 North America Oral Peptide Drug Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Oral Peptide Drug Market Size (2017-2028)
7.2 Europe Oral Peptide Drug Market Size by Country (2017-2022)
7.3 Europe Oral Peptide Drug Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Peptide Drug Market Size (2017-2028)
8.2 Asia-Pacific Oral Peptide Drug Market Size by Country (2017-2022)
8.3 Asia-Pacific Oral Peptide Drug Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Oral Peptide Drug Market Size (2017-2028)
9.2 Latin America Oral Peptide Drug Market Size by Country (2017-2022)
9.3 Latin America Oral Peptide Drug Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Peptide Drug Market Size (2017-2028)
10.2 Middle East & Africa Oral Peptide Drug Market Size by Country (2017-2022)
10.3 Middle East & Africa Oral Peptide Drug Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Detail
11.1.2 Allergan Business Overview
11.1.3 Allergan Oral Peptide Drug Introduction
11.1.4 Allergan Revenue in Oral Peptide Drug Business (2017-2022)
11.1.5 Allergan Recent Development
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Detail
11.2.2 Novo Nordisk Business Overview
11.2.3 Novo Nordisk Oral Peptide Drug Introduction
11.2.4 Novo Nordisk Revenue in Oral Peptide Drug Business (2017-2022)
11.2.5 Novo Nordisk Recent Development
11.3 Synergy Pharmaceuticals （Salix）
11.3.1 Synergy Pharmaceuticals （Salix） Company Detail
11.3.2 Synergy Pharmaceuticals （Salix） Business Overview
11.3.3 Synergy Pharmaceuticals （Salix） Oral Peptide Drug Introduction
11.3.4 Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2017-2022)
11.3.5 Synergy Pharmaceuticals （Salix） Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Oral Peptide Drug Introduction
11.4.4 Novartis Revenue in Oral Peptide Drug Business (2017-2022)
11.4.5 Novartis Recent Development
11.5 Chiasma
11.5.1 Chiasma Company Detail
11.5.2 Chiasma Business Overview
11.5.3 Chiasma Oral Peptide Drug Introduction
11.5.4 Chiasma Revenue in Oral Peptide Drug Business (2017-2022)
11.5.5 Chiasma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Oral Peptide Drug Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Linaclotide
Table 3. Key Players of Insulin
Table 4. Key Players of Plecanatide
Table 5. Key Players of Cyclosporine
Table 6. Key Players of Octreotide
Table 7. Global Oral Peptide Drug Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Oral Peptide Drug Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Oral Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Oral Peptide Drug Market Share by Region (2017-2022)
Table 11. Global Oral Peptide Drug Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Oral Peptide Drug Market Share by Region (2023-2028)
Table 13. Oral Peptide Drug Market Trends
Table 14. Oral Peptide Drug Market Drivers
Table 15. Oral Peptide Drug Market Challenges
Table 16. Oral Peptide Drug Market Restraints
Table 17. Global Oral Peptide Drug Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Oral Peptide Drug Market Share by Players (2017-2022)
Table 19. Global Top Oral Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2021)
Table 20. Ranking of Global Top Oral Peptide Drug Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Oral Peptide Drug Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Oral Peptide Drug Product Solution and Service
Table 24. Date of Enter into Oral Peptide Drug Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Oral Peptide Drug Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Oral Peptide Drug Revenue Market Share by Type (2017-2022)
Table 28. Global Oral Peptide Drug Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Oral Peptide Drug Revenue Market Share by Type (2023-2028)
Table 30. Global Oral Peptide Drug Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Oral Peptide Drug Revenue Market Share by Application (2017-2022)
Table 32. Global Oral Peptide Drug Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Oral Peptide Drug Revenue Market Share by Application (2023-2028)
Table 34. North America Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 35. North America Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 36. Europe Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 37. Europe Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 38. Asia-Pacific Oral Peptide Drug Market Size by Region (2017-2022) & (US$ Million)
Table 39. Asia-Pacific Oral Peptide Drug Market Size by Region (2023-2028) & (US$ Million)
Table 40. Latin America Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 41. Latin America Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 42. Middle East & Africa Oral Peptide Drug Market Size by Country (2017-2022) & (US$ Million)
Table 43. Middle East & Africa Oral Peptide Drug Market Size by Country (2023-2028) & (US$ Million)
Table 44. Allergan Company Detail
Table 45. Allergan Business Overview
Table 46. Allergan Oral Peptide Drug Product
Table 47. Allergan Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 48. Allergan Recent Development
Table 49. Novo Nordisk Company Detail
Table 50. Novo Nordisk Business Overview
Table 51. Novo Nordisk Oral Peptide Drug Product
Table 52. Novo Nordisk Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 53. Novo Nordisk Recent Development
Table 54. Synergy Pharmaceuticals （Salix） Company Detail
Table 55. Synergy Pharmaceuticals （Salix） Business Overview
Table 56. Synergy Pharmaceuticals （Salix） Oral Peptide Drug Product
Table 57. Synergy Pharmaceuticals （Salix） Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 58. Synergy Pharmaceuticals （Salix） Recent Development
Table 59. Novartis Company Detail
Table 60. Novartis Business Overview
Table 61. Novartis Oral Peptide Drug Product
Table 62. Novartis Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 63. Novartis Recent Development
Table 64. Chiasma Company Detail
Table 65. Chiasma Business Overview
Table 66. Chiasma Oral Peptide Drug Product
Table 67. Chiasma Revenue in Oral Peptide Drug Business (2017-2022) & (US$ Million)
Table 68. Chiasma Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Peptide Drug Market Share by Type: 2021 VS 2028
Figure 2. Linaclotide Features
Figure 3. Insulin Features
Figure 4. Plecanatide Features
Figure 5. Cyclosporine Features
Figure 6. Octreotide Features
Figure 7. Global Oral Peptide Drug Market Share by Application in 2021 & 2028
Figure 8. Hospital Case Studies
Figure 9. Retail Pharmacy Case Studies
Figure 10. Oral Peptide Drug Report Years Considered
Figure 11. Global Oral Peptide Drug Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Oral Peptide Drug Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Oral Peptide Drug Market Share by Region: 2021 VS 2028
Figure 14. Global Oral Peptide Drug Market Share by Players in 2021
Figure 15. Global Top Oral Peptide Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Peptide Drug as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Oral Peptide Drug Revenue in 2021
Figure 17. North America Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Oral Peptide Drug Market Share by Country (2017-2028)
Figure 19. United States Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Oral Peptide Drug Market Share by Country (2017-2028)
Figure 23. Germany Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Oral Peptide Drug Market Share by Region (2017-2028)
Figure 31. China Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Oral Peptide Drug Market Share by Country (2017-2028)
Figure 39. Mexico Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Oral Peptide Drug Market Share by Country (2017-2028)
Figure 43. Turkey Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Oral Peptide Drug Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Allergan Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 46. Novo Nordisk Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 47. Synergy Pharmaceuticals （Salix） Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 48. Novartis Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 49. Chiasma Revenue Growth Rate in Oral Peptide Drug Business (2017-2022)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock